Commerzbank Aktiengesellschaft’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,965
Closed -$221K 982
2016
Q3
$221K Sell
1,965
-182
-8% -$21K ﹤0.01% 817
2016
Q2
$266 Sell
2,147
-482
-18% -$58.2K ﹤0.01% 860
2016
Q1
$296K Sell
2,629
-383
-13% -$39.8K ﹤0.01% 873
2015
Q4
$328K Buy
3,012
+118
+4% +$13.5K ﹤0.01% 982
2015
Q3
$289K Sell
2,894
-319
-10% -$34.7K ﹤0.01% 962
2015
Q2
$366K Sell
3,213
-44
-1% -$5.33K ﹤0.01% 1043
2015
Q1
$340K Sell
3,257
-536
-14% -$57.1K ﹤0.01% 1028
2014
Q4
$456K Sell
3,793
-225
-6% -$29.6K ﹤0.01% 1021
2014
Q3
$588K Buy
4,018
+504
+14% +$77.8K ﹤0.01% 945
2014
Q2
$587K Buy
3,514
+856
+32% +$152K ﹤0.01% 955
2014
Q1
$527K Buy
2,658
+358
+16% +$67.6K ﹤0.01% 958
2013
Q4
$412K Sell
2,300
-50
-2% -$9.3K ﹤0.01% 1125
2013
Q3
$398K Sell
2,350
-8,057
-77% -$1.25M ﹤0.01% 1054
2013
Q2
$1.58M Buy
+10,407
New +$1.47M 0.01% 827

Other funds holding CLB

Commerzbank Aktiengesellschaft's CLB Position: Q4 2016 in Review

Commerzbank Aktiengesellschaft sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 1,965 shares — an estimated $221K sold.

Commerzbank Aktiengesellschaft first reported a position in CLB in Q2 2013 and held it in 14 quarters. The position peaked at $1.58M in Q2 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

  • Commerzbank Aktiengesellschaft reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 1,965 Core Laboratories shares in Q4 2016, an estimated $221K.
  • Commerzbank Aktiengesellschaft first reported a position in Core Laboratories in Q2 2013 and held it in 14 quarters.
  • Commerzbank Aktiengesellschaft's Core Laboratories position peaked at $1.58M in Q2 2013.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2016, filed 7 Feb 2017.